An open-label, randomized, four-way crossover study to evaluate the effect of food on the bioavailability of naproxen and esomeprazole from a PN 400 [esomeprazole/naproxen] tablet in healthy subjects

Trial Profile

An open-label, randomized, four-way crossover study to evaluate the effect of food on the bioavailability of naproxen and esomeprazole from a PN 400 [esomeprazole/naproxen] tablet in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Esomeprazole/naproxen (Primary)
  • Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
  • Focus Pharmacokinetics
  • Sponsors POZEN
  • Most Recent Events

    • 29 Jan 2010 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jun 2008 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top